Universal Biofuels, a subsidiary of Aemetis Inc (NASDAQ:AMTX), has completed an advanced biodiesel treatment plant construction in India to comply with the supply agreement signed with BP Singapore Pte Limited (BP).
The low cost feed stocks will be processed at the newly constructed plant in India into the good quality distilled biodiesel with low carbon for supply to BP. The Universal Biofuels plant in India uses high free fatty acid waste feed stocks and converts to high quality biodiesel while meeting the international standards.
Aemetis signed a 3 year accord with BP in May 2017 to supply biodiesel to the US and EU from the proposed biodiesel treatment plant in India. The Chief Executive Officer and Chairman, Mr. Eric MacAfee, said the construction of the advanced biodiesel treatment unit is now completed and the company will concentrate on commissioning/ processing of the low cost feed stocks and market good quality biodiesel in the international markets.
The company will begin production in April 2018 with expected inputs of feed stocks and the shipments are expected in Q2 2018 to BP. The Aemetis production plant based in Kakinada, Andhra Pradesh has an annual production capacity of fifty million gallons.
It is the only biofuels facility in India to get the nod to supply biofuels to California. The company has also filed a patent application for the process technology in the year 2017.
Brief Information about Aemetis Inc
The headquarters of Aemetis Inc, which was established in the year 2006, is located in Cupertino, California, in the US. An advanced biochemicals and renewable fuels company, Aemetis is engaged in the development, acquisition and commercialization of new technologies that help to replace conventional petroleum based products.
The California based ethanol production facility has an annual production capacity of 60 million gallons. The company also operates an advanced fuel and renewable chemicals production plant in India’s East Coast. This plant produces good quality distilled biodiesel as well as refined glycerin for India based customers and overseas customers in the US and EU.
This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.